Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Abbott

Showing results (91-100 of 421) with videos related to

Pageof 43
Sort By:
Communications Biology|July 10, 2020
The ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activatorKaitlyn E Redford, Geoffrey W Abbott
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacogenetics of drug-induced arrhythmiasGeoffrey W Abbott, Torsten K Roepke
Critical Reviews in Biochemistry and Molecular Biology|April 22, 2016
Ion channel-transporter interactionsDaniel L Neverisky, Geoffrey W Abbott
Communications Biology|November 9, 2019
In silico re-engineering of a neurotransmitter to activate KCNQ potassium channels in an isoform-specific mannerRían W Manville, Geoffrey W Abbott
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2020
Isoform-Selective KCNA1 Potassium Channel Openers Built from GlycineRían W Manville, Geoffrey W Abbott
Journal of Gambling Studies|May 27, 2003
A Reply to Gambino's "An Epidemiologic Note on Verification Bias: Implications for Estimation of Rates"Max W. Abbott, Rachel A. Volberg
The New Zealand Medical Journal|August 17, 1999
Differences in disease frequency between Europeans and Polynesians: directions for future research into genetic risk factorsW Abbott, R Scragg, J Marbrook
The Journal of Biological Chemistry|January 23, 1999
Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiationD W Abbott, J T Holt
Molecular Interventions|March 3, 2004
Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinK-related peptides (MiRPs)G W Abbott, S A Goldstein
International Journal of Epidemiology|October 1, 1994
Lifetime prevalence estimates of pathological gambling in New ZealandR A Volberg, M W Abbott
Pageof 43

Showing results (91-100 of 421) with videos related to

Sort By:
Pageof 43
Communications Biology|July 10, 2020
The ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activatorKaitlyn E Redford, Geoffrey W Abbott
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacogenetics of drug-induced arrhythmiasGeoffrey W Abbott, Torsten K Roepke
Critical Reviews in Biochemistry and Molecular Biology|April 22, 2016
Ion channel-transporter interactionsDaniel L Neverisky, Geoffrey W Abbott
Communications Biology|November 9, 2019
In silico re-engineering of a neurotransmitter to activate KCNQ potassium channels in an isoform-specific mannerRían W Manville, Geoffrey W Abbott
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2020
Isoform-Selective KCNA1 Potassium Channel Openers Built from GlycineRían W Manville, Geoffrey W Abbott
Journal of Gambling Studies|May 27, 2003
A Reply to Gambino's "An Epidemiologic Note on Verification Bias: Implications for Estimation of Rates"Max W. Abbott, Rachel A. Volberg
The New Zealand Medical Journal|August 17, 1999
Differences in disease frequency between Europeans and Polynesians: directions for future research into genetic risk factorsW Abbott, R Scragg, J Marbrook
The Journal of Biological Chemistry|January 23, 1999
Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiationD W Abbott, J T Holt
Molecular Interventions|March 3, 2004
Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinK-related peptides (MiRPs)G W Abbott, S A Goldstein
International Journal of Epidemiology|October 1, 1994
Lifetime prevalence estimates of pathological gambling in New ZealandR A Volberg, M W Abbott
Pageof 43